The m-CCRP aims to improve the recovery of acute respiratory failure survivors utilizing a mobile care coordinator. The NIH-funded randomized controlled trial will evaluate the success of m-CCRP in improving the health-related quality of life as well as the cognitive, physical and psychological functioning of ARF survivors. Dr. Khan and colleagues will also determine if m-CCRP reduces future health care utilization by ICU survivors.

Patients who have prolonged stays, getting intubated and sedated, may experience severe hallucinations, putting them at risk of PTSD for years to come, studies show.

For years it has been known that many patients who survive critical illness do not return to their original state of health, resulting in long-term consequences of critical illness.1Weakness acquired in the intensive care unit (ICU) is a physical consequence occurring in 25% to 80% of patients who receive mechanical ventilation for more than 4 days and in 50% to 75% of patients with sepsis. Nearly all patients affected with ICU-acquired weakness have symptoms that persist years later.1,2 Issues with cognitive function occur in 30% to 80% of ICU survivors and include memory, planning, problem-solving, visual-spatial, and processing problems.1,3 Cognitive consequences may improve during the months after discharge. However, 25% of patients with adult respiratory distress syndrome (ARDS) have long-term persistent cognitive impairment 6 years after discharge.